Clinical Trials
4 trialsNCT04133948 2025-03-10
DONIMI
The Netherlands Cancer Institute
Phase 1/2 Completed
NCT04393753 2024-05-08
MERKLIN2
4SC AG
Phase 2 Completed
NCT03278665 2022-02-04
SENSITIZE
4SC AG
Phase 1/2 Completed
NCT04874831 2021-11-18
Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1)
4SC AG
Phase 2 Withdrawn